Nachrichten zur Bausch + Lomb Corp. Aktie

Fitch Ratings upgraded its credit grade on both Bausch + Lomb Corp. and its parent company Bausch Health Cos., but…

The year is 1910. Rochester’s local startup — Kodak — is growing rapidly. Bausch & Lomb and Gleason too.…

These are the stocks posting the largest moves in midday trading.…

Bausch + Lomb credit rating upgraded to ’B’ at S&P, parent company outlook developing…

…

While the top- and bottom-line numbers for Bausch + Lomb (BLCO) give a sense of how the business performed in…

Bausch + Lomb (BLCO) delivered earnings and revenue surprises of 4.17% and 1.17%, respectively, for the quarter ended December 2024.…

Looking beyond Wall Streets top -and-bottom-line estimate forecasts for Bausch + Lomb (BLCO), delve into some of its key metrics…

TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) -- InflammX Therapeutics Inc., a clinical-stage biotechnology company focused on developing…

BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances…

Bausch + Lomb down after report that Blackstone could back away from takeover bid…

Private equity group likely to drop out of consortium with TPG exploring bid for eyecare group…

…

Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a…

Sale process comes after tensions between investors and creditors over plan to split from Bausch Health…

Bausch Health Cos. is working with Jefferies Financial Group to explore refinancing some of its debt to aid a long-planned…

Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical…

Bausch + Lomb (BLCO) witnessed a jump in share price last session on above-average trading volume. The latest trend in…

Bausch + Lomb explores sale amid parent companys debt woes - report…

Bausch & Lomb stock surged on reports the American-Canadian eye health products firm is exploring a sale as it seeks…

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription…

Earnings call: Bausch + Lomb sees robust growth, raises guidance…

Bausch + Lomb shares climb on earnings beat, raised outlook…

Bausch + Lomb (BLCO) shares have started gaining and might continue moving higher in the near term, as indicated by…

Bausch + Lomb board welcomes new director Karen Ling…